Get Premium to unlock powerful stock data
Black Diamond Therapeutics Inc logo

Black Diamond Therapeutics Inc

$ 1.81 -0.16 (-8.12%) 10:08 PM EST
P/E:
At Loss
P/B:
0.40
Market Cap:
$ 65.69M
Enterprise V:
$ -80.00M
Volume:
122.53K
Avg Vol (2M):
252.72K
Volume:
122.53K
Market Cap $:
65.69M
PE Ratio:
At Loss
Avg Vol (2-Month):
252.72K
Enterprise Value $:
-80.00M
PB Ratio:
0.40
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Black Diamond Therapeutics Inc
NAICS : 325412 SIC : 2834
One Main Street, 10th Floor, Cambridge, MA, USA, 02142
Description
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under pipeline are BDTX-189 and BDTX-1535.
Name Current Vs Industry Vs History
Cash-To-Debt 6.36
Equity-to-Asset 0.79
Debt-to-Equity 0.16
Debt-to-EBITDA -0.23
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -76.1
3-Year EPS without NRI Growth Rate -40.9
3-Year FCF Growth Rate -66.9

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 33.17
9-Day RSI 30.35
14-Day RSI 31.23
6-1 Month Momentum % -54.58
12-1 Month Momentum % -85.76

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 9.67
Quick Ratio 9.67
Cash Ratio 9.23

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -37.5
Name Current Vs Industry Vs History
ROE % -53.97
ROA % -44.99
ROIC % -466.44
ROC (Joel Greenblatt) % -495.2
ROCE % -49.15

Financials (Next Earnings Date:2022-08-12 Est.)

BDTX's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:BDTX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Performance
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -3.33
Beta 0
Volatility % 53.94
14-Day RSI 31.23
14-Day ATR ($) 0.204292
20-Day SMA ($) 2.262
12-1 Month Momentum % -85.76
52-Week Range ($) 1.77 - 24.0735
Shares Outstanding (Mil) 36.29

Piotroski F-Score Details

Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Black Diamond Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More